# SGLT2 Inhibitors in Treating Patients With PCOS

> **NCT05966792** · NA · COMPLETED · sponsor: **Shanghai 10th People's Hospital** · enrollment: 82 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** SGLT2 inhibitors
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT05966792
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-10
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05966792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05966792, "SGLT2 Inhibitors in Treating Patients With PCOS". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05966792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*